CompoAtlas

D-HIST

Natural health product licensed in Canada

Licence holder
Ortho Molecular Products Inc.
NPN or DIN-HM
80033623
Status
Active licence
Licence date
13 July 2012
Revision date
Not provided
Form
Capsule végétale
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Bromélaïne de tige

Potency : 1,800,000 FCC PU

50 mgNot calculated
Bromélaïne de tige

Potency : 120 GDU

Not specifiedNot calculated
Vitamine C

Source : Acide ascorbique

150 mgNot calculated

Non-medicinal ingredients

Hypromellose, Stéarate de magnésium végétal, Acide stéarique, Dioxyde de silicium, Calcium silicate, Microcrystalline cellulose

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Capsule2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps the body to metabolize fats and proteins. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps in connective tissue formation. Helps in wound healing. Source of antioxidants to reduce oxidative stress/damage for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80033623

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line